Latest ANIK reports update at 2024-03-15: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Anika Therapeutics
  4. Financial Ratios
Anika Therapeutics logo
Anika Therapeutics ANIK
$ 25.57 -0.04%
mail-toReport an Error

Anika Therapeutics Financial Ratios 2011-2024 | ANIK

Annual Financial Ratios Anika Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -4.5 -27.3 110.8 -21.9 22.3 29.3 31.2 22.4 18.3 15.0 22.9 12.0 14.0

P/S

 2.2 2.6 3.1 4.0 5.3 5.2 8.8 7.1 6.0 5.4 6.3 2.0 1.8

EPS

 -5.6 -1.0 0.3 -1.7 1.9 1.3 2.2 2.2 2.1 2.6 1.5 0.9 0.7

EV (Enterprise Value)

 300 M 319 M 364 M 431 M 491 M 474 M 880 M 643 M 476 M 491 M 429 M 130 M 121 M

EBITDA per Share

 -5.54 -0.87 0.63 -1.56 2.85 1.92 3.43 3.7 3.48 4.51 2.63 2.02 1.38

EV/EBITDA

 38.7 -429.8 11.2 16.6 17.2 11.5 8.7 7.2 11.0 4.0 5.2

PEG

 -0.43 0.26 -1.86 0.73 0.46 -0.72 -17.34 2.89 -0.87 0.19 0.36 0.33 0.15

P/B

 1.4 1.2 1.3 1.4 2.1 2.1 3.8 3.3 2.7 3.2 3.5 1.3 1.3

P/CF

 -208.5 92.0 54.5 40.3 17.7 18.1 31.2 74.6 18.8 15.0 19.1 15.6 13.6

ROE %

 -38.95 -5.20 1.44 -8.80 9.43 7.10 12.07 14.61 14.59 21.52 15.17 10.79 8.93

ROA %

 -30.55 -4.26 1.19 -6.56 8.22 6.71 11.26 13.55 13.05 19.75 13.19 8.28 6.37

ROCE %

 -41.29 -6.79 0.91 -10.40 10.89 8.12 16.97 21.87 22.03 32.68 22.02 17.44 11.81

Current Ratio

 - - - - 14.4 18.3 15.8 19.4 10.2 23.3 10.2 5.4 4.4

DSO

 77.3 75.3 66.6 66.0 73.5 71.8 76.7 97.4 85.0 59.3 91.1 109.8 97.5

DIO

 247.3 220.7 231.4 202.6 279.3 293.3 293.9 242.8 259.0 216.4 176.3 104.3 99.5

DPO

 54.4 48.7 46.8 38.1 48.7 36.7 90.0 35.0 143.9 20.9 44.8 29.5 58.6

Operating Cycle

 324.6 296.0 298.0 268.6 352.8 365.1 370.6 340.2 344.0 275.6 267.4 214.1 197.0

Cash Conversion Cycle

 270.2 247.3 251.2 230.6 304.1 328.4 280.6 305.3 200.0 254.7 222.6 184.6 138.4

All numbers in USD currency

Quarterly Financial Ratios Anika Therapeutics

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.19 -0.71 - -0.29 -0.2 -0.2 - 0.04 0.45 0.2 -1.1 -0.45 -0.54 0.41 0.28 0.65 0.68 0.32 0.54 0.53 0.69 -0.46 0.55 0.47 0.78 0.38 0.56 0.61 0.59 0.46 0.74 0.56 0.52 0.24 0.53 0.42 0.63 1.04 0.47 0.36 0.44 0.23 0.33 0.12 0.28 0.15 0.22 0.23 0.18 0.03

EBITDA per Share

 -0.11 -0.75 - -0.06 -0.1 -0.13 - 0.42 0.78 0.2 - -0.24 -0.22 0.69 - 1.17 1.07 0.49 - 0.91 0.97 -0.43 - 0.93 1.35 0.62 - 1.13 1.05 0.78 - 1.06 0.95 0.43 - 0.94 1.2 1.73 - 0.83 0.86 0.46 - 0.46 0.63 0.31 - 0.61 0.44 0.12

ROE %

 -7.66 -7.65 -3.49 -3.29 -1.64 1.64 3.50 -2.25 -4.80 -9.91 -8.80 -1.65 3.89 9.99 9.43 10.95 10.64 11.20 7.10 7.24 6.97 7.45 12.07 12.64 14.05 13.60 14.61 16.22 16.17 16.02 14.59 13.74 13.23 14.74 21.52 22.03 22.22 21.35 15.17 14.36 12.22 11.30 10.79 9.74 11.37 10.35 8.93 3.14 2.41 0.34

ROA %

 -6.29 -6.31 -2.91 -2.76 -0.54 1.26 2.74 -1.54 -3.45 -7.36 -6.56 -1.05 3.48 8.44 8.22 9.76 9.71 10.47 6.71 6.80 6.51 6.92 11.26 11.77 13.06 12.62 13.55 14.87 14.69 14.43 13.05 12.42 12.04 13.52 19.78 19.99 19.98 18.97 13.19 12.06 10.04 8.90 8.28 7.30 8.39 7.48 6.37 2.24 1.72 0.24

ROCE %

 -9.92 -9.77 -4.46 -4.01 -1.53 2.85 4.10 1.19 -2.16 -8.87 -3.81 0.37 7.46 15.09 10.21 13.46 12.54 12.67 4.55 8.44 9.09 11.55 13.66 19.81 22.06 21.37 17.00 23.23 23.31 23.16 14.73 20.51 20.06 22.70 27.71 33.44 33.39 31.78 16.35 18.85 15.63 14.33 10.95 16.03 18.61 16.86 9.55 5.08 3.88 0.59

Current Ratio

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 69.4 36.9 - - - 37.1 - 71.3 66.9 67.3 67.3 69.4 71.7 60.8 70.7 70.9 69.2 80.9 70.3 70.8 62.1 95.7 74.0 80.0 65.0 100.3 87.7 97.7 94.7 100.8 64.0 83.4 86.3 114.1 67.3 71.0 59.6 48.1 80.5 96.3 82.1 120.3 86.6 132.6 99.8 123.2 85.6 85.6 97.8 -

DIO

 249.8 245.3 - 97.2 108.6 218.3 - 215.2 225.3 304.6 - 293.8 249.0 219.1 232.1 337.3 293.6 270.2 277.6 234.7 238.4 252.0 230.7 321.7 318.4 285.1 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 50.3 54.5 - 21.8 23.0 46.2 - 44.3 44.2 60.5 - 57.1 48.4 41.2 40.4 58.8 51.1 43.5 41.0 34.6 35.2 57.5 70.6 98.5 97.5 67.9 - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 319.1 282.2 - 97.2 108.6 255.4 - 286.5 292.2 372.0 67.3 363.2 320.7 279.9 302.8 408.2 362.8 351.1 347.9 305.4 300.5 347.7 304.7 401.7 383.4 385.5 87.7 97.7 94.7 100.8 64.0 83.4 86.3 114.1 67.3 71.0 59.6 48.1 80.5 96.3 82.1 120.3 86.6 132.6 99.8 123.2 85.6 85.6 97.8 -

Cash Conversion Cycle

 268.9 227.6 - 75.4 85.7 209.2 - 242.1 248.0 311.5 67.3 306.1 272.2 238.8 262.4 349.4 311.7 307.6 307.0 270.8 265.3 290.2 234.0 303.2 285.9 317.6 87.7 97.7 94.7 100.8 64.0 83.4 86.3 114.1 67.3 71.0 59.6 48.1 80.5 96.3 82.1 120.3 86.6 132.6 99.8 123.2 85.6 85.6 97.8 -

All numbers in USD currency